H-151是一种选择性刺痛抑制剂,具有治疗神经血管与年龄相关的黄斑退化症的潜力
Miruto Tanaka1, Hiroto Yasuda1, Shinsuke Nakamura1
1Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
Investigative ophthalmology & visual science
|July 9, 2024
概括
抑制干扰素基因 (STING) 途径的循环氨酸单酸-氨酸单酸合成酶 (cGAS) 刺激器抑制了小鼠的异常眼球血管生成. 这种STING抑制剂治疗减少了胆道新血管化 (CNV) 的发展和泄漏.
科学领域:
- 免疫学 免疫学 免疫学
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
背景情况:
- 干扰素基因 (STING) 途径的循环氨酸单酸-氨酸单酸合成酶 (cGAS) 刺激器是细胞质双链DNA (dsDNA) 的关键先天免疫传感器.
- 这条通路在炎症反应中起着至关重要的作用,并与各种疾病有关.
研究的目的:
- 研究cGAS-STING通路在胆道新血管化 (CNV) 中的作用,这是视力丧失的主要原因.
- 评估一种STING抑制剂在CNV小鼠模型中的治疗潜力.
主要方法:
- 在C57BL/6J小鼠中使用激光光凝诱导CNV.
- 分析了cGAS和STING的表达,并使用了西式涂抹.
- 一种STING抑制剂,H-151,在诱导后被静脉内注射.
- 评估了CNV大小,血管泄漏和下游信号分子.
主要成果:
- 在CNV诱导后的RPE-choroid复合体中,cGAS和STING表达显著上调.
- 内H-151的使用有效地抑制了中枢神经病毒的发展,并减少了新血管的泄漏.
- H-151治疗减弱了下游的炎症信号,包括NF-κB酸化和IL-1β表达,特别是在巨细胞中.
结论:
- 在 CNV 发育过程中,cGAS-STING 途径被激活.
- 抑制cGAS-STING通路表明对异常的眼球血管生成有治疗作用.
- 针对cGAS-STING途径提供了治疗CNV的潜在策略.
相关概念视频
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:27Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427